219 related articles for article (PubMed ID: 31817119)
1. Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.
Grases F; Costa-Bauza A
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817119
[TBL] [Abstract][Full Text] [Related]
2. Phytate Dephosphorylation Products Also Act as Potent Inhibitors of Calcium Oxalate Crystallization.
Grases F; Costa-Bauzá A; Calvó P; Julià F; Dietrich J; Gomila RM; Martorell G; Sanchis P
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080228
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of inositol phosphates in urine after topical administration of myo-inositol hexaphosphate to female Wistar rats.
Grases F; Costa-Bauzá A; Berga F; Rodríguez A; Gomila RM; Martorell G; Martínez-Cignoni MR
Life Sci; 2018 Jan; 192():33-37. PubMed ID: 29155299
[TBL] [Abstract][Full Text] [Related]
4. Intake of myo-inositol hexaphosphate and urinary excretion of inositol phosphates in Wistar rats: Gavage vs. oral administration with sugar.
Grases F; Costa-Bauzá A; Berga F; Gomila RM; Martorell G; Martínez-Cignoni MR
PLoS One; 2019; 14(10):e0223959. PubMed ID: 31626632
[TBL] [Abstract][Full Text] [Related]
5. Effect of Phytate (InsP6) and Other Inositol-Phosphates (InsP5, InsP4, InsP3, InsP2) on Crystallization of Calcium Oxalate, Brushite, and Hydroxyapatite.
Calvó P; Costa-Bauza A; Grases F
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509097
[TBL] [Abstract][Full Text] [Related]
6. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.
Grases F; Perelló J; Prieto RM; Simonet BM; Torres JJ
Life Sci; 2004 May; 75(1):11-9. PubMed ID: 15102518
[TBL] [Abstract][Full Text] [Related]
7. Plant phosphates, phytate and pathological calcifications in chronic kidney disease.
Buades Fuster JM; Sanchís Cortés P; Perelló Bestard J; Grases Freixedas F
Nefrologia; 2017; 37(1):20-28. PubMed ID: 27697413
[TBL] [Abstract][Full Text] [Related]
8. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats.
Grases F; Sanchis P; Perello J; Isern B; Prieto RM; Fernandez-Palomeque C; Fiol M; Bonnin O; Torres JJ
Front Biosci; 2006 Jan; 11():136-42. PubMed ID: 16146720
[TBL] [Abstract][Full Text] [Related]
9. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment.
Grases F; Costa-Bauzá A
Anticancer Res; 1999; 19(5A):3717-22. PubMed ID: 10625946
[TBL] [Abstract][Full Text] [Related]
10. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption.
Grases F; Isern B; Perelló J; Sanchis P; Prieto RM
Front Biosci; 2005 Jan; 10():799-802. PubMed ID: 15569619
[TBL] [Abstract][Full Text] [Related]
11. Dephosphorylation of myo-inositol phosphates in the in vitro intestinal Caco-2 cell model.
Briviba K; Schollenberger M; Rodehutscord M; Greiner R
Int J Food Sci Nutr; 2018 Feb; 69(1):46-51. PubMed ID: 28554270
[TBL] [Abstract][Full Text] [Related]
12. Study of a myo-inositol hexaphosphate-based cream to prevent dystrophic calcinosis cutis.
Grases F; Perelló J; Isern B; Prieto RM
Br J Dermatol; 2005 May; 152(5):1022-5. PubMed ID: 15888163
[TBL] [Abstract][Full Text] [Related]
13. Interactions between supplemented mineral phosphorus and phytase on phytate hydrolysis and inositol phosphates in the small intestine of broilers1,2.
Zeller E; Schollenberger M; Witzig M; Shastak Y; Kühn I; Hoelzle LE; Rodehutscord M
Poult Sci; 2015 May; 94(5):1018-29. PubMed ID: 25810408
[TBL] [Abstract][Full Text] [Related]
14. Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion.
Prieto RM; Fiol M; Perello J; Estruch R; Ros E; Sanchis P; Grases F
Eur J Nutr; 2010 Sep; 49(6):321-6. PubMed ID: 20108098
[TBL] [Abstract][Full Text] [Related]
15. Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats.
Grases F; Sanchis P; Perelló J; Isern B; Prieto RM; Fernández-Palomeque C; Torres JJ
Circ J; 2007 Jul; 71(7):1152-6. PubMed ID: 17587727
[TBL] [Abstract][Full Text] [Related]
16. Influence of concomitant food intake on the excretion of orally administered myo-inositol hexaphosphate in humans.
Grases F; Costa-Bauza A; Perelló J; Isern B; Vucenik I; Valiente M; Muñoz JA; Prieto RM
J Med Food; 2006; 9(1):72-6. PubMed ID: 16579731
[TBL] [Abstract][Full Text] [Related]
17. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
Saw NK; Chow K; Rao PN; Kavanagh JP
J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
[TBL] [Abstract][Full Text] [Related]
18. Inositol phosphates have novel anticancer function.
Shamsuddin AM
J Nutr; 1995 Mar; 125(3 Suppl):725S-732S. PubMed ID: 7884558
[TBL] [Abstract][Full Text] [Related]
19. Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial.
Sanchis P; Calvo P; Pujol A; Rivera R; Berga F; Fortuny R; Costa-Bauza A; Grases F; Masmiquel L
Nutr Diabetes; 2023 Feb; 13(1):2. PubMed ID: 36854678
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Myo-Inositol Hexaphosphate (Phytate) on Abdominal Aortic Calcification in Patients With Chronic Kidney Disease.
Sanchis P; Buades JM; Berga F; Gelabert MM; Molina M; Íñigo MV; García S; Gonzalez J; Bernabeu MR; Costa-Bauzá A; Grases F
J Ren Nutr; 2016 Jul; 26(4):226-36. PubMed ID: 26975775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
